发明名称 Pharmaceutical composition
摘要 The present invention provides compounds of Formula I:; along with pharmaceutical compositions containing the same, and methods of use thereof in subjects in need of treatment.
申请公布号 US9000024(B2) 申请公布日期 2015.04.07
申请号 US201414173170 申请日期 2014.02.05
申请人 Eisai R&D Management Co., Ltd. 发明人 Spyvee Mark;Satoh Takashi;Carlson Jonathan Eric
分类号 C07D231/22;C07D231/20 主分类号 C07D231/22
代理机构 Myers Bigel Sibley & Sajovec, P.A. 代理人 Myers Bigel Sibley & Sajovec, P.A.
主权项 1. A method of treating cancer in a mammal, comprising the step of administering to the mammal a pharmaceutical composition comprising a compound of formula I:wherein: one of R1a and R1b is hydrogen, and the other is methyl; or R1a and R1b are taken together to form a cyclopropyl ring; R2 is methyl or fluoromethyl; R3 is methyl; R4 is hydrogen, halo, fluoromethyl, methyl, methoxy, or fluoromethoxy; R5 is hydrogen, halo, fluoromethyl, methyl, methoxy, or fluoromethoxy; R6 is hydrogen, halo, methyl, or methoxy; R7 is hydrogen, halo, methyl, or methoxy; and X is oxygen;or a pharmaceutically acceptable salt thereof, wherein the cancer is selected from the group consisting of skin cancer, breast cancer, colorectal cancer, prostate cancer, kidney cancer, ovarian cancer, cervical cancer, endometrial cancer, glioblastoma, lung cancer, head and neck cancer, medulloblastoma, and urinary tract cancer.
地址 Tokyo JP